CYP3A- hæmmere såsom azolsvampemidler, HIV- proteasehæmmere, clarithromycin, telithromycin, verapamil, diltiazem, indinavir, ciprofloxacin og grapefrugtjuice forventes ikke at have en signifikant virkning på den aktive metabolits farmakokinetik.
Therefore, CYP3A inhibitors such as azol antifungals, HIV protease inhibitors, clarithromycin, telithromycin, verapamil, diltiazem, indinavir, ciprofloxacin, and grapefruit juice are not anticipated to have a significant effect on the pharmacokinetics of the active metabolite.